Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis

Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis

Abstract Introduction Clinical guidelines offer little guidance for treatment selection following inadequate response to conventional synthetic disease-modifying antirheumatic drug (csDMARD) in rheumatoid arthritis (RA). A molecular signature response classifier (MSRC) was validated to predict tumor...

Full description

Bibliographic Details
Main Authors: Jeffrey R. Curtis, Vibeke Strand, Steven J. Golombek, George A. Karpouzas, Lixia Zhang, Angus Wong, Krishna Patel, Jennifer Dines, Viatcheslav R. Akmaev
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Rheumatology and Therapy
Subjects:
Molecular signature
Precision medicine
Response classifier
Rheumatoid arthritis
Treatment selection
Online Access:https://doi.org/10.1007/s40744-023-00618-1

Internet

https://doi.org/10.1007/s40744-023-00618-1

Similar Items